{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:38:53Z","timestamp":1760056733383,"version":"build-2065373602"},"reference-count":261,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T00:00:00Z","timestamp":1390348800000},"content-version":"vor","delay-in-days":386,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jacc.2012.12.002","type":"journal-article","created":{"date-parts":[[2013,1,14]],"date-time":"2013-01-14T18:39:13Z","timestamp":1358188753000},"page":"357-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Highlights of the Year in JACC 2012"],"prefix":"10.1016","volume":"61","author":[{"given":"Anthony N.","family":"DeMaria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen J.","family":"Bax","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory K.","family":"Feld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry H.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Hlatky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilbur Y.W.","family":"Lew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o A.C.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehtisham","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan S.","family":"Maisel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjiv M.","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven E.","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Sahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotirios","family":"Tsimikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2012.12.002_bib1","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jacc.2012.02.022","article-title":"Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies","volume":"59","author":"Genereux","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib2","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jacc.2011.11.048","article-title":"Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation","volume":"59","author":"Sinning","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib3","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.jacc.2012.07.035","article-title":"Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve","volume":"60","author":"Urena","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jacc.2011.10.857","article-title":"Transapical aortic valve implantation: incidence and predictors of paravalvular leakage and transvalvular regurgitation in a series of 358 patients","volume":"59","author":"Unbehaun","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jacc.2011.08.069","article-title":"Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure","volume":"59","author":"Toggweiler","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib6","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.jacc.2012.02.020","article-title":"Transcatheter aortic valve replacement: outcomes of patients with moderate or severe mitral regurgitation","volume":"59","author":"Toggweiler","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib7","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2011.10.877","article-title":"Sex-related differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosis","volume":"59","author":"Hayashida","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib8","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jacc.2012.05.009","article-title":"Sex differences in mortality after transcatheter aortic valve replacement for severe aortic stenosis","volume":"60","author":"Humphries","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib9","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic valve replacement in high risk patients","volume":"365","author":"Smith","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.12.002_bib10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jacc.2012.03.075","article-title":"Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis","volume":"60","author":"Reynolds","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib11","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jacc.2012.07.003","article-title":"Vascular complications after transcatheter aortic valve replacement","volume":"60","author":"Genereux","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib12","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jacc.2012.09.001","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation","volume":"60","author":"Kappetein","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jacc.2011.09.045","article-title":"Deformation dynamics and mechanical properties of the aortic annulus by 4-dimensional computed tomography","volume":"59","author":"Hamdan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib14","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jacc.2011.11.045","article-title":"Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation","volume":"59","author":"Jilaihawi","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib15","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jacc.2011.12.015","article-title":"3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement","volume":"59","author":"Willson","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jacc.2011.09.061","article-title":"Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation","volume":"59","author":"Amat-Santos","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib17","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.jacc.2012.01.008","article-title":"A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial","volume":"59","author":"von Birgelen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib18","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jacc.2012.07.004","article-title":"2-year patient-related versus stent-related outcomes: the SORT OUT IV (Scandinavian Organization for Randomized Trials With Clinical Outcome IV) trial","volume":"60","author":"Jensen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib19","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jacc.2011.11.047","article-title":"Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation","volume":"59","author":"Song","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib20","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jacc.2012.07.040","article-title":"SeQuent Please World Wide Registry: clinical results of SeQuent Please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study","volume":"60","author":"Wohrle","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib21","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jacc.2012.01.015","article-title":"A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study","volume":"59","author":"Rittger","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib22","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/j.jacc.2012.02.027","volume":"59","author":"Belkacemi","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib23","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jacc.2011.12.016","article-title":"Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent","volume":"59","author":"Meredith","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib24","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jacc.2012.01.073","article-title":"Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute MI: 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute MI) trial","volume":"60","author":"Hofma","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib25","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jacc.2011.10.883","article-title":"Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008","volume":"59","author":"Brennan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib26","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jacc.2011.10.909","article-title":"In-stent neoatherosclerosis: a final common pathway of late stent failure","volume":"59","author":"Park","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib27","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jacc.2012.07.008","article-title":"Reduction in mortality as a result of direct transport from the field to a receiving center for primary percutaneous coronary intervention","volume":"60","author":"Le May","year":"2012","journal-title":"JAm Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib28","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/j.jacc.2012.07.050","article-title":"Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation","volume":"60","author":"Mehta","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib29","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.jacc.2012.06.017","article-title":"Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study","volume":"60","author":"Romagnoli","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib30","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/j.jacc.2012.09.019","article-title":"Radial approach for primary PCI: ready for prime time?","volume":"60","author":"Bertrand","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib31","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jacc.2011.09.079","article-title":"Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation","volume":"59","author":"Tearney","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib32","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jacc.2011.09.078","article-title":"Morphometric assessment of coronary stenosis relevance with optical coherence tomography: a comparison with fractional flow reserve and intravascular ultrasound","volume":"59","author":"Gonzalo","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib33","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jacc.2011.08.082","article-title":"Diagnosis of spontaneous coronary artery dissection by optical coherence tomography","volume":"59","author":"Alfonso","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib34","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jacc.2011.11.003","article-title":"Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study","volume":"59","author":"Sen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib35","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.jacc.2012.03.007","article-title":"Safety and efficacy of a monoclonal antibody to proprotein convertase subtilisin\/kexin type 9 serine protease, SAR236553\/REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy","volume":"59","author":"McKenney","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib36","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.jacc.2011.11.064","article-title":"Discovery of a new role of human resistin in hepatocyte low-density lipoprotein receptor suppression mediated in part by proprotein convertase subtilisin\/kexin type 9","volume":"59","author":"Melone","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib37","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jacc.2012.05.056","article-title":"A diagnosis of the metabolic syndrome in youth that resolves by adult life is associated with a normalization of high carotid intima-media thickness and type 2 diabetes mellitus risk: the Bogalusa Heart and Cardiovascular Risk in Young Finns studies","volume":"60","author":"Magnussen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib38","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jacc.2012.03.060","article-title":"High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis and coronary events","volume":"60","author":"Mackey","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib39","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jacc.2012.03.058","article-title":"High-density lipoprotein particle number: a better measure to quantify high-density lipoprotein?","volume":"60","author":"deGoma","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib40","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jacc.2011.11.038","article-title":"Dietary intervention prevents dyslipidemia associated with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected individuals","volume":"59","author":"Lazzaretti","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib41","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jacc.2011.11.037","article-title":"Nutritional therapy to prevent dyslipidemia in patients starting antiretroviral therapy for human immunodeficiency virus","volume":"59","author":"Stein","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib42","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jacc.2011.11.034","article-title":"Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension","volume":"59","author":"Brandt","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib43","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2012.05.042","article-title":"Pilot trial of cryoplasty or conventional balloon post-dilation of nitinol stents for revascularization of peripheral arterial segments: the COBRA trial","volume":"60","author":"Banerjee","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib44","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2012.04.035","article-title":"Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial","volume":"60","author":"Rastan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib45","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.jacc.2011.11.035","article-title":"The PROFI study (Prevention of Cerebral Embolization by Proximal Balloon Occlusion Compared to Filter Protection During Carotid Artery Stenting): a prospective randomized trial","volume":"59","author":"Bijuklic","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib46","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jacc.2012.07.026","article-title":"Pre-procedural risk quantification for carotid stenting using the CAS score: a report from the NCDR CARE Registry","volume":"60","author":"Hawkins","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib47","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.jacc.2012.06.037","article-title":"The problem with asymptomatic cerebral embolic complications in vascular procedures: what if they are not asymptomatic?","volume":"60","author":"Gress","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib48","article-title":"Endovascular repair of ascending aortic dissection: a novel treatment option for patients judged unfit for direct surgical repair","author":"Lu","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib49","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.jacc.2012.07.033","article-title":"Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis","volume":"60","author":"Stabile","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib50","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.jacc.2012.08.989","article-title":"A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: one year results from the ACHILLES trial","volume":"60","author":"Scheinert","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib51","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1016\/j.jacc.2012.08.1016","article-title":"Zotarolimus-eluting peripheral stents for the treatment of erectile dysfunction in subjects with suboptimal response to phosdodiesterase-5 inhibitors","volume":"60","author":"Rogers","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib52","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1016\/j.jacc.2012.09.032","article-title":"Endovascular treatment for erectile dysfunction: an old paradigm revisited","volume":"60","author":"Shishehbor","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib53","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","article-title":"A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)","volume":"60","author":"Kim","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib54","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jacc.2012.04.057","article-title":"Double antiplatelet therapy after drug-eluting stent implantation: risk associated with discontinuation within the first year","volume":"60","author":"Ferreira-Gonz\u00e1lez","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib55","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jacc.2012.02.044","volume":"60","author":"Sibbing","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib56","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2012.03.050","article-title":"Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study","volume":"60","author":"Alexopoulos","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib57","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.jacc.2011.11.068","article-title":"Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) study","volume":"59","author":"Price","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib58","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jacc.2011.12.024","article-title":"A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers","volume":"59","author":"Frelinger","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib59","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jacc.2012.03.030","article-title":"Mortality benefit with prasugrel I the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis","volume":"60","author":"Smith","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib60","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2012.02.026","article-title":"A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents","volume":"59","author":"Trenk","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib61","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.jacc.2012.02.042","article-title":"Recovery of platelet function after discontinuation of a prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease","volume":"59","author":"Price","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib62","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.jacc.2011.12.039","article-title":"Pharmacodynamic effects of prasugrel dosing regimens in patients on maintenance prasugrel therapy","volume":"59","author":"Tello-Montoliu","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib63","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jacc.2012.09.014","article-title":"Discontinuation of long-term clopidogrel therapy is associated with death and myocardial infarction after saphenous vein graft percutaneous coronary intervention","volume":"60","author":"Sachdeva","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib64","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.jacc.2012.08.964","article-title":"Reduction in platelet reactivity with prasugrel 5 mg in low-body-weight patients is noninferior to prasugrel 10 mg in higher-body-weight patients: results from the FEATHER trial","volume":"60","author":"Erlinge","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib65","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.jacc.2012.04.062","article-title":"The risk of adverse cardiac and bleeding events following noncardiac surgery relative to antiplatelet therapy in patients with prior percutaneous coronary intervention","volume":"60","author":"Singla","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib66","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jacc.2012.03.019","article-title":"Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation","volume":"60","author":"Lip","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib67","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jacc.2012.05.012","article-title":"Danger ahead: watch out for indirect comparisons!","volume":"60","author":"Cannon","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib68","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jacc.2012.06.019","article-title":"Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation","volume":"60","author":"Apostolakis","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib69","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.jacc.2012.06.039","article-title":"Mechanical valve thrombosis with dabigatran","volume":"60","author":"Price","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib70","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.jacc.2012.07.048","article-title":"Influence of baseline and worsening renal function on efficacy of spironolactone in patients with severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study)","volume":"60","author":"Vardeny","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib71","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/j.jacc.2012.08.971","article-title":"Moderate renal insufficiency does not attenuate the clinical benefit of aldosterone antagonists in heart failure","volume":"60","author":"Kiernan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib72","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/j.jacc.2012.07.056","article-title":"Novel protein therapeutics for systolic heart failure: chronic subcutaneous b-type natriuretic peptide","volume":"60","author":"Chen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib73","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.jacc.2012.08.991","article-title":"Subcutaneous B-type natriuretic peptide for treatment of heart failure: a dying therapy reborn?","volume":"60","author":"Ahmad","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib74","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/j.jacc.2012.07.068","article-title":"Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer","volume":"60","author":"Chen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib75","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/j.jacc.2012.08.1005","article-title":"Progression of heart failure from AHA\/ACC stage A to stage B or even C: can we all agree we should try to prevent this from happening","volume":"60","author":"Lenihan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib76","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.jacc.2012.07.067","article-title":"Effect of statin therapy on the risk of incident heart failure in breast cancer patients receivining anthracycline chemotherapy: an observational clinical cohort study","volume":"60","author":"Seicean","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib77","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.jacc.2012.08.1000","article-title":"Statins in preparation for chemotherapy: \u201cdo these medications help your fitness for battle?\u201d","volume":"60","author":"Lenihan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib78","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.jacc.2012.05.065","article-title":"Intravenous iron alone is equally effective with the combination of iron and erythropoietin for the treatment of iron-deficiency anemia in advanced heart failure","volume":"60","author":"Terrovitis","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib79","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.jacc.2012.08.1010","article-title":"6-minute walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure","volume":"60","author":"Forman","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib80","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.jacc.2012.08.968","article-title":"Prognostic value of self-reported versus objectively measured functional capacity in patients with heart failure: results from the TIME-CHF (Trial of Intensified Versus Standard Medical Therapy in Elderly Patients With Congestive Heart Failure)","volume":"60","author":"Spruit","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib81","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.jacc.2011.12.030","article-title":"Targeted left ventricular lead placement to guide cardiac resynchronization therapy","volume":"59","author":"Khan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib82","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jacc.2012.01.018","article-title":"The next frontier of clinical trials","volume":"59","author":"Ghali","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib83","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.jacc.2012.01.020","article-title":"Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?","volume":"59","author":"Swedberg","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib84","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.jacc.2012.01.019","article-title":"It is all about heart rate. or is it?","volume":"59","author":"Sarraf","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib85","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.jacc.2012.07.052","article-title":"Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices","volume":"60","author":"Uriel","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib86","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.jacc.2012.08.978","article-title":"Ramping up evidence-based ventricular assist device care","volume":"60","author":"Rogers","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib87","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jacc.2011.08.064","article-title":"Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry","volume":"59","author":"Priori","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib88","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jacc.2012.05.014","article-title":"Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant","volume":"60","author":"Brignole","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib89","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jacc.2012.05.016","article-title":"Defibrillation testing: should the paradigm shift?","volume":"60","author":"Estes","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib90","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jacc.2011.10.891","article-title":"Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review","volume":"59","author":"Ganesan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib91","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jacc.2011.08.081","article-title":"AV junction ablation in heart failure patients with atrial fribrillation treated with cardiac resynchronization therapy: the picture is now clear!","volume":"59","author":"Gasparini","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib92","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.jacc.2012.06.053","article-title":"AV junction ablation in heart failure patients with atrial fribrillation treated with cardiac resynchronization therapy: the picture is now clear","volume":"60","author":"Olde Nordkamp","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib93","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jacc.2006.10.062","article-title":"Mortality trends in patients diagnosed with first atrial fibrillation a 21-year community-based study","volume":"49","author":"Miyasaka","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib94","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.jacc.2012.06.048","article-title":"n","volume":"60","author":"Swartz","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib95","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.hrthm.2010.06.030","article-title":"Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation","volume":"7","author":"Mahnkopf","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2012.12.002_bib96","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jacc.2011.10.879","article-title":"Atrial conduction slows immediately before the onset of human atrial fibrillation: a bi-atrial contact mapping study of transitions to atrial fibrillation","volume":"59","author":"Lalani","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib97","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jacc.2012.05.022","article-title":"Treatment of atrial fibrillation by the ablation of localized sources: the Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation: CONFIRM tial","volume":"60","author":"Narayan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib98","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jacc.2008.11.054","article-title":"Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the \u201csecond factor\u201d","volume":"53","author":"Stiles","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib99","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.jacc.2012.07.031","article-title":"Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study","volume":"60","author":"Deftereos","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib100","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.jacc.2012.07.032","article-title":"Colchicine after pulmonary vein isolation to prevent the early recurrence of atrial fibrillation: mollifying an inflammatory response?","volume":"60","author":"Marcus","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib101","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.amjcard.2009.03.044","article-title":"Five-year outcomes after segmental pulmonary vein isolation for paroxysmal atrial fibrillation","volume":"104","author":"Sawhney","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib102","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.hrthm.2011.12.016","article-title":"2012 HRS\/EHRA\/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design","volume":"9","author":"Calkins","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2012.12.002_bib103","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMoa1113566","article-title":"Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation","volume":"367","author":"Nielsen","year":"2012","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jacc.2012.12.002_bib104","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.hrthm.2009.06.009","article-title":"Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries","volume":"6","author":"Ellis","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2012.12.002_bib105","doi-asserted-by":"crossref","DOI":"10.1111\/jce.12000","article-title":"Acute termination of human atrial fibrillation by identification and catheter ablation of localized rotors and sources: first multicenter experience of focal impulse and rotor modulation (FIRM) ablation","author":"Shivkumar","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib106","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jacc.2012.05.036","article-title":"A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension","volume":"60","author":"Pokushalov","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib107","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/CIRCULATIONAHA.104.533190","article-title":"Response of atrial fibrillation to pulmonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction","volume":"112","author":"Verma","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.12.002_bib108","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/01.CIR.0000151289.73085.36","article-title":"Recovered Pulmonary Vein Conduction as a Dominant Factor for Recurrent Atrial Tachyarrhythmias After Complete Circular Isolation of the Pulmonary Veins: Lessons From Double Lasso Technique","volume":"111","author":"Ouyang","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.12.002_bib109","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/CIRCULATIONAHA.106.678789","article-title":"Radiofrequency ablation of atrial fibrillation: is the persistence of all intraprocedural targets necessary for long-term maintenance of sinus rhythm?","volume":"117","author":"Pratola","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.12.002_bib110","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jacc.2011.09.076","article-title":"Histopathologic characterization of chronic radiofrequency ablation lesions for pulmonary vein isolation","volume":"59","author":"Kowalski","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib111","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jacc.2011.12.055","article-title":"Hybrid thoracoscopic surgical and transvenous catheter ablation of atrial fibrillation","volume":"60","author":"Pison","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib112","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jacc.2012.01.068","article-title":"Hybrid thoracoscopic and transvenous catheter ablation of atrial fibrillation: is this the answer we are searching for?","volume":"60","author":"Calkins","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib113","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jacc.2011.11.051","article-title":"Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation","volume":"59","author":"Mohanty","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib114","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jacc.2012.03.042","article-title":"Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation","volume":"60","author":"Munger","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jacc.2011.08.068","article-title":"Procedural Complications, Rehospitalizations, and Repeat Procedures After Catheter Ablation for Atrial Fibrillation","volume":"59","author":"Shah","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib116","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jacc.2011.10.896","article-title":"Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study","volume":"59","author":"Flaker","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib117","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jacc.2011.12.014","article-title":"Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry","volume":"59","author":"Lakkireddy","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib118","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jacc.2011.11.044","article-title":"Anticoagulation for atrial fibrillation ablation: what is the optimal strategy?","volume":"59","author":"Knight","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib119","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jacc.2012.04.042","article-title":"Connexin43 gene transfer reduces ventricular tachycardia susceptibility after myocardial infarction","volume":"60","author":"Greener","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib120","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jacc.2012.05.020","article-title":"Gap junctions, slow conduction, and ventricular tachycardia after myocardial infarction","volume":"60","author":"Saffitz","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib121","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jacc.2012.03.044","article-title":"Endo-epicardial homogenization of the scar versus limited substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy","volume":"60","author":"Di Biase","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib122","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jacc.2009.05.033","article-title":"Improving our understanding of epicardial ventricular tachycardia in nonischemic cardiomyopathy","volume":"54","author":"Shivkumar","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib123","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jacc.2011.11.030","article-title":"Electroanatomic remodeling of the left stellate ganglion after myocardial infarction","volume":"59","author":"Han","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib124","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/01.CIR.102.7.742","article-title":"Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy","volume":"102","author":"Nademanee","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.12.002_bib125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jacc.2011.09.043","article-title":"Bilateral cardiac sympathetic denervation for the management of electrical storm","volume":"59","author":"Ajijola","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib126","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jacc.2012.06.022","article-title":"Duration of myocardial early systolic lengthening predicts the presence of significant coronary artery disease","volume":"60","author":"Smedsrud","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib127","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.jacc.2012.09.007","article-title":"Relations of long-term and contemporary lipid levels and lipid genetic risk score with coronary artery calcium in the Framingham Heart Study","volume":"60","author":"Tsao","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib128","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jacc.2012.05.045","article-title":"Adolescence risk factors are predictive of coronary artery calcification at middle age","volume":"60","author":"Hartiala","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib129","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jacc.2012.05.044","article-title":"The child is father of the man","volume":"60","author":"Hecht","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib130","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jacc.2011.10.886","article-title":"ACIC (Advanced Cardiovascular Imaging Consortium) Coronary computed tomography angiography after stress testing","volume":"59","author":"Chinnaiyan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib131","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jacc.2011.11.016","article-title":"Computed tomography coronary angiography","volume":"59","author":"De Feyter","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib132","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.jacc.2012.08.981","article-title":"Prognostic value of multi-detector coronary computed tomograpic angiography in relation to exercise electrocardiogram in patients with suspected coronary artery disease","volume":"60","author":"Cho","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib133","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.jacc.2012.08.980","article-title":"Improving the odds in the evaluation of chest pain","volume":"60","author":"Taylor","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib134","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.jacc.2012.05.062","article-title":"Coronary computed tomographic angiography as a gatekeeper to invasive diagnostic and surgical procedures: results from the Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) registry","volume":"60","author":"Shaw","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib135","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jacc.2011.10.890","article-title":"Prognostic value of myocardial contrast delayed enhancement with 64-slice multidetector computed tomography after acute myocardial infarction","volume":"59","author":"Sato","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib136","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.jacc.2012.09.023","article-title":"Molecular PET\/CT imaging of cardiac angiotensin ii type 1 receptors","volume":"60","author":"Fukushima","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib137","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.jacc.2012.09.022","article-title":"Cardiac PET-CT Imaging of the rennin-angiotensin system in humans holds promise for image-guided approach to heart failure therapy","volume":"60","author":"Schindler","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib138","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jacc.2012.02.061","article-title":"Impact of ischemia-guided revascularization with myocardial perfusion imaging for patients with multivessel coronary disease","volume":"60","author":"Kim","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib139","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jacc.2012.04.015","article-title":"Should ischemia guide revascularization?","volume":"60","author":"Weintraub","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib140","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.jacc.2011.12.040","volume":"59","author":"Jaarsma","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib141","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.jacc.2012.07.038","article-title":"Does rubidium-82 PET have superior accuracy to spect perfusion imaging for the diagnosis of obstructive coronary disease?: a systematic review and meta-analysis","volume":"60","author":"McArdle","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib142","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.jacc.2012.05.052","article-title":"Quantification of absolute myocardial perfusion in patients with coronary artery disease: comparison between cardiovascular magnetic resonance and positron emission tomography","volume":"60","author":"Morton","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib143","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.jacc.2012.05.051","article-title":"Quantification of myocardial perfusion and myocardial perfusion reserve by positron emission tomography and cardiovascular magnetic resonance imaging","volume":"60","author":"Gerber","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib144","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jacc.2012.02.075","article-title":"Validation of dynamic 3-dimensional whole heart magnetic resonance myocardial perfusion imaging against fractional flow reserve for the detection of significant coronary artery disease","volume":"60","author":"Jogiya","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib145","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.jacc.2012.01.055","article-title":"Myocardial oxygenation in coronary artery disease: insights from blood oxygen level\u2013dependent magnetic resonance imaging at 3 Tesla","volume":"59","author":"Arnold","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib146","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.jacc.2012.01.056","article-title":"BOLD new directions in myocardial ischemia imaging: myocardial oxygenation assessment by cardiac magnetic resonance","volume":"59","author":"Weinsaft","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib147","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jacc.2011.11.025","article-title":"Myocardial viability imaging: dead or alive?","volume":"59","author":"Wu","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib148","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jacc.2011.09.073","article-title":"Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy","volume":"59","author":"Gerber","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib149","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2012.03.076","article-title":"Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy","volume":"60","author":"Todiere","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib150","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jacc.2012.05.023","article-title":"Hypertrophic cardiomyopathy: refining the lens of cardiac magnetic resonance to evaluate late gadolinium enhancement","volume":"60","author":"Bluemke","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib151","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jacc.2012.02.070","article-title":"Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation","volume":"60","author":"Klem","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib152","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jacc.2012.02.071","article-title":"Scaring myocardial scars: new targets for the electrical fairy?","volume":"60","author":"Mewton","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib153","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jacc.2011.09.066","article-title":"Patient management after noninvasive cardiac imaging results from SPARC (Study of Myocardial Perfusion and Coronary Anatomy Imaging Roles in Coronary Artery Disease)","volume":"59","author":"Hachamovitch","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib154","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacc.2012.04.020","article-title":"Modeling serum biomarrkers S100B and NSE as predictors of outcome following out-of-hospital cardiac arrest: an aid to clinical decision making","volume":"60","author":"Einav","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib155","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2012.04.022","article-title":"Predicting full recovery after out of hospital cardiac arrest","volume":"60","author":"Comess","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib156","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jacc.2012.04.024","article-title":"Elevated plasma levels of neuropeptide proenkephalin a predict morality and functional outcome in ischemic stroke","volume":"60","author":"Doehner","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib157","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jacc.2012.03.056","article-title":"Prospective study on circulating mircoRNAs and risk of myocardial infarction","volume":"60","author":"Zampetaki","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib158","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2012.04.018","article-title":"Small RNA biomarkers come of age","volume":"60","author":"Engelhardt","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib159","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jacc.2012.04.049","article-title":"Improving the primary prevention of cardiovascular events by using biomarkers to identify individuals with silent heart disease","volume":"60","author":"Nadir","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib160","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jacc.2012.05.030","article-title":"Biomarkers and silent cardiac disease in primary prevention: time to unmask the damage","volume":"60","author":"Richards","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib161","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.jacc.2012.01.051","article-title":"Impact of coronary plaque composition on cardiac troponinelevation after percutaneous coronary intervention in stable angina pectoris: a computed tomorgraphy analysis","volume":"59","author":"Watabe","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib162","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.jacc.2012.01.053","article-title":"Predicting periprocedural myocardial infarction: target-lesion plaque characterization with coronary computed tomography angiography","volume":"59","author":"Malpeso","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib163","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","article-title":"Galectin-3, a marker of cardiac fibrosis, predicts incident heart falure in the community","volume":"60","author":"Ho","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib164","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.jacc.2012.05.032","article-title":"Galectin-3 in cardiovascular disease: a possible window into early myocardial fibrosis","volume":"60","author":"Morrow","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib165","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jacc.2011.10.875","article-title":"Chronic hyperglycemia and subclincal myocardial injury","volume":"59","author":"Rubin","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib166","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jacc.2011.10.874","article-title":"Low levels of circulating troponin as an intermediate phenotype in the pathway to heart failure","volume":"59","author":"De Lemos","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib167","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jacc.2012.06.018","article-title":"Family history of premature death and risk of early-onset cardiovascular disease","volume":"60","author":"Ranthe","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib168","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jacc.2012.03.047","article-title":"Subclinical hypothyroidism is associated with increased risk of all-cause and cardiovascular mortality in adults","volume":"60","author":"Tseng","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib169","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jacc.2011.09.067","article-title":"Meta-analysis of statin effects in women versus men","volume":"59","author":"Kostis","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib170","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.jacc.2011.12.035","article-title":"On-treatment non-high-density lipoprotein cholesterol, apolipoprotein b, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy","volume":"59","author":"Mora","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib171","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.jacc.2012.06.050","article-title":"The impact of reducing cardiovascular medication copayments on health spending and resource utilization","volume":"60","author":"Choudhry","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib172","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jacc.2012.05.019","article-title":"Statins, risk of diabetes, and implications on outcomes in the general population","volume":"60","author":"Wang","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib173","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2012.04.040","article-title":"Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease","volume":"60","author":"Blumenthal","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib174","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jacc.2011.11.013","article-title":"Changes in fitness and fatness on the development of cardiovascular disease risk factors","volume":"59","author":"Lee","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib175","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.jacc.2012.05.037","article-title":"Body composition and survival in stable coronary heart disease","volume":"60","author":"Lavie","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib176","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jacc.2012.07.029","article-title":"Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension","volume":"60","author":"Geisler","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib177","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.jacc.2012.07.020","article-title":"The National Cardiovascular Data Registry (NCDR) data quality brief","volume":"60","author":"Messenger","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib178","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jacc.2012.04.026","article-title":"Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999\u20132010","volume":"60","author":"Guo","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib179","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.jacc.2012.02.029","article-title":"Temporal trends in infective endocarditis in the context of prophylasix guidelines modifications","volume":"59","author":"Duval","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib180","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.jacc.2012.02.030","article-title":"The changing epidemiology of infective endocarditis","volume":"59","author":"Wang","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib181","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.jacc.2012.09.003","article-title":"Preventing sudden death of athletes with electrocardiographic screening: what is the absolute benefit and how much will it cost?","volume":"60","author":"Halkin","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib182","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jacc.2012.08.996","article-title":"Is the cost the reason for missing the ECG advantages?","volume":"60","author":"Pelliccia","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib183","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jacc.2012.02.051","article-title":"Adrenergic-pathway gene variants influence beta-blocker-related outcomes after acute coronary syndrome in a race-specific manner","volume":"60","author":"Cresci","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib184","doi-asserted-by":"crossref","first-page":"e44324","DOI":"10.1371\/journal.pone.0044324","article-title":"Combinatorial pharmacogenetic interactions of bucindolol and beta(1), alpha(2c) adrenergic receptor polymorphisms","volume":"7","author":"O'Connor","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jacc.2012.12.002_bib185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature06007","article-title":"Variants conferring risk of atrial fibrillation on chromosome 4q25","volume":"448","author":"Gudbjartsson","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2012.12.002_bib186","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/eurheartj\/ehn578","article-title":"Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation","volume":"30","author":"Kaab","year":"2009","journal-title":"Euro Heart J"},{"key":"10.1016\/j.jacc.2012.12.002_bib187","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jacc.2012.01.070","article-title":"Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation","volume":"60","author":"Parvez","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib188","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jacc.2012.02.060","article-title":"Can polymorphisms predict response to antiarrhythmic drugs in atrial fibrillation?","volume":"60","author":"Daubert","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib189","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jacc.2012.04.030","article-title":"Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillation","volume":"60","author":"Ritchie","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib190","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jacc.2012.04.031","article-title":"The complex genetics of atrial fibrillation","volume":"60","author":"Judge","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib191","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jacc.2012.03.031","article-title":"Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia","volume":"60","author":"Jamshidi","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib192","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ng1790","article-title":"A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization","volume":"38","author":"Arking","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2012.12.002_bib193","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/hmg\/ddn341","article-title":"Identification of a common variant at the NOS1AP locus strongly associated to QT-interval duration","volume":"18","author":"Eijgelsheim","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jacc.2012.12.002_bib194","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng.364","article-title":"Common variants at ten loci influence QT interval duration in the QTGEN Study","volume":"41","author":"Newton-Cheh","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2012.12.002_bib195","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jacc.2011.11.039","article-title":"Epistatic effects of potassium channel variation on cardiac repolarization and atrial fibrillation risk","volume":"59","author":"Mann","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib196","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7326\/0003-4819-115-3-209","article-title":"Lipoprotein(a) and atherosclerosis","volume":"115","author":"Scanu","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2012.12.002_bib197","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jacc.2012.01.078","article-title":"Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism","volume":"60","author":"Helgadottir","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib198","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jacc.2012.04.038","article-title":"Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies","volume":"60","author":"Tsimikas","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib199","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jacc.2012.04.037","article-title":"Spectrum and prevalence of mutations involving brs1- through brs12-susceptibility genes in a cohort of unrelated patients referred for brugada syndrome genetic testing: implications for genetic testing","volume":"60","author":"Crotti","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib200","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jacc.2012.05.011","article-title":"Genetic testing in brugada syndrome","volume":"60","author":"Kaufman","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib201","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jacc.2012.02.017","article-title":"Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery disease","volume":"59","author":"Barbato","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib202","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jacc.2012.05.050","article-title":"R222Q SCN5A mutation is associated with reversible ventricular ectopy and dilated cardiomyopathy","volume":"60","author":"Mann","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib203","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jacc.2012.02.068","article-title":"Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives","volume":"60","author":"Maron","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib204","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in Lamin A\/C mutation carriers: a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib205","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jacc.2011.10.869","article-title":"Prevention of sudden death for patients with cardiomyopathies another step forward","volume":"59","author":"Maron","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib206","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacc.2011.08.077","article-title":"Increased expression of adenosine triphosphate-sensitive K+ channels in mitral dysfunction: mechanically stimulated transcription and hypoxia-induced protein stability?","volume":"59","author":"Raeis-Dauve","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib207","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jacc.2011.09.056","article-title":"Hypoxia-induced adaptation to mitral regurgitation: a role for K ATP channel up-regulation?","volume":"59","author":"Lopaschuk","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib208","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jacc.2012.04.027","article-title":"S100A12 expression in thoracic aortic aneurysm is associated with increased risk of dissection and perioperative complications","volume":"60","author":"Das","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib209","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jacc.2011.10.876","article-title":"On male-specific estrogen action: good for the gander?","volume":"59","author":"Banka","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib210","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jacc.2011.09.054","article-title":"Transcriptome characterization of estrogen-treated human myocardium identifies myosin regulatory light chain interacting protein as a sex-specific element influencing contractile function","volume":"59","author":"Kararigas","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib211","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.jacc.2012.02.043","article-title":"Nonfasting glucose, ischemic heart disease, and myocardial infarction: a Mendelian randomization study","volume":"59","author":"Benn","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib212","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jacc.2012.02.066","article-title":"Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells","volume":"60","author":"Itzhaki","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib213","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jacc.2012.04.019","article-title":"The unstoppable attraction for induced pluripotent stem cells: are they the magic bullet for modeling inherited arrhythmogenic diseases?","volume":"60","author":"Gnecchi","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib214","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.jacc.2012.02.033","article-title":"Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease","volume":"59","author":"Xu","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib215","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jacc.2011.09.075","article-title":"Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease","volume":"59","author":"Wang","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib216","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jacc.2012.01.067","article-title":"Clinical application of cardiovascular pharmacogenetics","volume":"60","author":"Voora","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib217","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jacc.2011.11.029","article-title":"Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells","volume":"59","author":"Li","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib218","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacc.2012.04.047","article-title":"Human cardiac progenitor cells engineered with pim-I kinase enhance myocardial repair","volume":"60","author":"Mohsin","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib219","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2012.05.025","article-title":"A longer, better ride with engineered stem cells","volume":"60","author":"Bishopric","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib220","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.jacc.2011.12.062","article-title":"Genes and coronary artery disease: where are we?","volume":"60","author":"Roberts","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib221","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacc.2011.09.022","article-title":"Hypoplastic left heart syndrome: current considerations and expectations","volume":"59","author":"Feinstein","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib222","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jacc.2011.10.878","article-title":"Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry","volume":"59","author":"Pahl","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib223","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jacc.2011.11.049","article-title":"Predictors of survival after single-ventricle palliation: the impact of right ventricular dominance","volume":"59","author":"D'Udekem","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib224","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jacc.2011.12.021","article-title":"The functionally univentricular heart: which is better\u2014right or left ventricle","volume":"59","author":"Backer","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib225","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.jacc.2012.01.022","article-title":"Long-term outcome following catheter valvotomy for pulmonary atresia with intact ventricular septum","volume":"59","author":"Chubb","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib226","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.jacc.2012.03.020","article-title":"Outcome of cardiac surgery in patients 50 years of age or older with Ebstein anomaly: survival and functional improvement","volume":"59","author":"Attenhofer Jost","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib227","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.jacc.2012.07.041","article-title":"Staged left ventricular recruitment following single ventricle palliation in patients with borderline left heart hypoplasia","volume":"60","author":"Emani","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib228","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.jacc.2012.08.987","article-title":"Atrioventricular valve annular remodeling with a bioabsorbable ring in young children","volume":"60","author":"Bautista-Hernandez","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib229","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2012.06.031","article-title":"Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation","volume":"60","author":"Cappato","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib230","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jacc.2012.06.032","article-title":"Ivabradine: a ray of hope for inappropriate sinus tachycardia","volume":"60","author":"Scheinman","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib231","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jacc.2012.04.055","volume":"60","author":"Benetos","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib232","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.jacc.2012.08.973","article-title":"Vascular responses to long- and short-term exposure to fine particulate matter: the MESA Air (Multi-Ethnic Study of Atherosclerosis and Air Pollution)","volume":"60","author":"Krishnan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib233","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.jacc.2012.08.974","article-title":"Chronic air pollution exposure and endothelial dysfunction: what you can't see\u2014can harm you","volume":"60","author":"Brook","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib234","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jacc.2011.08.062","article-title":"Myocardial redox state predicts in-hospital clinical outcome after cardiac surgery effects of short-term pre-operative statin treatment","volume":"59","author":"Antoniades","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib235","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jacc.2011.08.063","article-title":"Acute effects of statins","volume":"59","author":"Laufs","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib236","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jacc.2012.01.066","article-title":"Ramapril sensitizes platelets to nitric oxide: implications for therapy in high risk patients","volume":"60","author":"Willoughby","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib237","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jacc.2012.02.046","article-title":"Targeting platelet nitric oxide resistance with ramipril: unraveling mechanisms of atherothrombotic risk reduction with angiotensin-converting enzyme inhibitors","volume":"60","author":"Angiolillo","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib238","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jacc.2011.08.066","article-title":"PET\/MRI of inflammation in myocardial infarction","volume":"59","author":"Lee","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib239","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jacc.2011.09.047","article-title":"Monocytes on the scar's edge","volume":"59","author":"Frantz","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib240","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jacc.2011.07.051","article-title":"Cardiac uses of phosphodiesterase-5 inhibitors","volume":"59","author":"Schwartz","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib241","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.jacc.2011.09.086","article-title":"Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection","volume":"59","author":"Kukreja","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib242","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.jacc.2012.01.060","article-title":"Cyclic adenosine monophosphate phosphodiesterase type 4 protects against atrial arrhythmias","volume":"59","author":"Molina","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib243","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.jacc.2012.03.027","article-title":"Phosphodiesterase-4 activity: a critical modulator of atrial contractility and arrhythmogenesis","volume":"59","author":"Van Wagoner","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib244","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jacc.2011.07.053","article-title":"A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice","volume":"59","author":"Matsubara","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib245","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jacc.2011.09.050","article-title":"Dipeptidyl peptidase-4 inhibitor: another player for cardiovascular protection","volume":"59","author":"Murohara","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib246","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jacc.2012.02.082","article-title":"Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link!","volume":"60","author":"Marzilli","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib247","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jacc.2012.03.071","article-title":"Pre-hospital electrocardiography by emergency medical ppersonnel: effects on scene and transport times for chest pain and ST-segment elevation myocardial infarction patients","volume":"60","author":"Patel","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib248","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.jacc.2012.01.050","article-title":"Appropriateness of coronary revascularization for patients without acute coronary syndromes","volume":"59","author":"Hannan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib249","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.jacc.2012.08.979","article-title":"Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes and net reclassification of cardiovascular events","volume":"60","author":"Tsimikas","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib250","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jacc.2011.12.054","article-title":"Outcome of patients with aortic stenosis, small valve area, and low-flow, low-gradient despite preserved left ventricular ejection fraction","volume":"60","author":"Clavel","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib251","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jacc.2011.12.053","article-title":"Low-flow, low-gradient aortic stenosis with preserved ejection fraction","volume":"60","author":"Baumgartner","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib252","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jacc.2012.03.052","article-title":"Impact of metabolic syndrome on progression of aortic stenosis","volume":"60","author":"Capoulade","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib253","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.jacc.2012.01.024","article-title":"Do bisphosphonates slow the progression of aortic stenosis?","volume":"59","author":"Aksoy","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib254","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jacc.2011.08.072","article-title":"Clinical outcome in asymptomatic severe aortic stenosis","volume":"59","author":"Lancellotti","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib255","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jacc.2011.10.855","article-title":"Varying hemodynamics and differences in prognosis in patients with asymptomatic severe aortic stenosis and preserved ejection fraction","volume":"59","author":"Flachskampf","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib256","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/j.jacc.2012.08.988","article-title":"Asymptomatic left ventricular systolic dysfunction in patients with severe aortic stenosis: characteristics and outcomes","volume":"60","author":"Henkel","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib257","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jacc.2012.05.029","article-title":"Early anticoagulation of bioprosthetic aortic valves in older patients","volume":"60","author":"Brennan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib258","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jacc.2012.06.014","article-title":"Prevention of thromboembolic events after bioprosthetic aortic valve replacement","volume":"60","author":"Whitlock","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib259","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jacc.2011.08.067","article-title":"Acute and 12 month results with catheter-based mitral valve leaflet repair","volume":"59","author":"Whitlow","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib260","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jacc.2011.09.049","article-title":"An option for the high-comorbidity patient with mitral regurgitation","volume":"59","author":"Turi","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.12.002_bib261","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.jacc.2012.06.055","article-title":"Does pregnancy influence the durability of human aortic valve substitutes?","volume":"60","author":"Arabkhani","year":"2012","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109712058378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109712058378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:56:32Z","timestamp":1760014592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109712058378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":261,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0735109712058378"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2012.12.002","relation":{},"ISSN":["0735-1097"],"issn-type":[{"type":"print","value":"0735-1097"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highlights of the Year in JACC 2012","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2012.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}